期刊文献+

糖尿病性视网膜病变玻璃体切割术后再出血的探讨 被引量:7

原文传递
导出
摘要 玻璃体切割术已成为目前治疗增殖型糖尿病性视网膜病变(proliferativediabeticretinop—athy,PDR)主要手段之一。此手术可使发生严重出血而不能自行吸收的PDR患者视力得到明显提高,也可使大量玻璃体出血后机化增殖收缩致视网膜脱离的患者网膜复位、恢复部分视力。但是糖尿病性视网膜病变玻璃体切割术后玻璃体腔的再出血(postvitrectomydiabeticvitreoushemorrhagePDVH)是糖网玻切术后最常见的并发症之一,发生率为12%-63%。它不仅严重影响患者术后视力的恢复及医生对其眼底情况的常规检查,还可能使患者面临二次手术,以清除积血。部分严重患者可因长期高眼压或牵拉网脱致失明。现对其发生的原因及早期防治和处理做一综述。
出处 《中国实用眼科杂志》 CSCD 北大核心 2012年第12期1405-1407,共3页 Chinese Journal of Practical Ophthalmology
作者简介 通信作者:隋桂琴,Email:suijingjing2008@sina.com.
  • 相关文献

参考文献23

  • 1杨钧主编.现代眼科手册[M].人民卫生出版社,1993:463-465.
  • 2West JF,Gregor ZJ. Fibrovascular ingrowth and recurrent haem- orrhage following diabetic vitrectomy.[J]Br J Ophthalmol,2000, 84: 822.
  • 3Koutsandrea CN, Apostolopoulos MN, Chatzoulis DZ.Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage[J].Acta Ophthalmol Scand,2001,79:34.
  • 4马先祯 王兴荣 毕宏生等.曲安奈德玻璃体腔注射结合玻璃体切割手术治疗增值性糖尿病性视网膜病变[J].国际眼科杂志,2007,8(4):112-112.
  • 5Cleod D.Br J Ophthalmol,2000,84(8):810.
  • 6王启常.糖尿病玻璃体手术后的玻璃体出血[J].国外医学(眼科学分册),2001,25(4):248-250. 被引量:12
  • 7张淑芳.眼内出血所致的青光眼.见:李美玉.眼科全书[M].中册.北京:人民卫生出版社,1996:1924.
  • 8陶勇,姜燕荣,黎晓新,尹虹,赵明威.增殖型糖尿病视网膜病变玻璃体手术与虹膜红变发生的关系[J].中华糖尿病杂志(1006-6187),2005,13(5):332-334. 被引量:20
  • 9Smith R. Diabetic retinopathy and cataract surgery [J]. Br JOphthalmol, 1991,75: 1.
  • 10Pollack A,Dotan S, Oliver M. Course of diabetic retinopa- thy following cataract surgery[J].Br J Ophthalmol,1991,75:2-8.

二级参考文献43

  • 1Kumagai K. Introduction of a new method for the preparation of triamcinolone acctonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina, 2003, 23(6):881-882.
  • 2Jonas JB, Sofker A, Hayler J, et al. lntravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy? Acta Ophthalmol Scand, 2003,81 (6) :663-665.
  • 3Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol, 2002, 240(6):423-429.
  • 4Hollborn M, Birkenmeier G, Saalbach A, et al. Expression of LRP1 in retinal pigment epithelial cells and its regulation by growth factors. Invest Ophthalmol Vis Sci, 2004, 45(6) :2033-2038.
  • 5Enaida H, Hata Y, Ueno A, et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina, 2003,23(6) :764-770.
  • 6Furino C, Micelli Ferrari T, Boscia F, et al. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina,2003, 23(6) :771-776.
  • 7Jonas JB. Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment. Br J Ophthalmol, 2004, 88(4) :587-588.
  • 8Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol, 2003, 135(2) :243-246.
  • 9Matsumoto H, Enaida H, Hisatomi T, et al. Retinal detachment in morning glory syndrome treated by triamcinolone acetonide-assisted pars plana vitrectomy. Retina, 2003, 23(4):569-572.
  • 10Fraser EA, Cheema RA, Roberts MA. Triamcinolone acetonideassisted peeling of retinal internal limiting membrane for macular surgery. Retina, 2003, 23(6):883-884.

共引文献53

同被引文献37

引证文献7

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部